WORLD
Novartis In-licenses COVID-19 Treatment Ensovibep from Molecular Partners - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners ...'
Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners https://t.co/x8Sfc72CqW pic.twitter.com/spFLVUmhQu— Reuters (@Reuters) January 10, 2022
(The above story first appeared on LatestLY on Jan 10, 2022 01:16 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
